Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma
Clinical trial NCT01976208 · COMPLETED
Trial details
- NCT number
- NCT01976208
- Sponsor
- Shanghai Zhangjiang Biotechnology Limited Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2015-12-01
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.